Patents by Inventor Ingvild Dybdrodt Amundsen

Ingvild Dybdrodt Amundsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MIXTURE OF HMOS FOR IMPROVING THE MICROBIOTA OF PREGNANT WOMEN
    Publication number: 20230012011
    Abstract: The invention relates to a human milk oligosaccharide (HMO) for use in supplementing the diet of a pregnant woman, a synthetic composition comprising an HMO for use in supplementing the diet of a pregnant woman, and a method for improving health outcomes in an infant by supplementing the diet of a pregnant woman.
    Type: Application
    Filed: November 30, 2020
    Publication date: January 12, 2023
    Inventors: Bruce McConnell, Louise Kristine Vigsnæs, Dorthe Seitzberg, Ingvild Dybdrodt Amundsen, Buket Soyyilmaz
  • MIXTURE OF HMOs
    Publication number: 20230000886
    Abstract: The invention relates to a human milk oligosaccharide (HMO) for use in, a synthetic composition comprising an HMO for use in, and a method for prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in a lac-tose-intolerant, IBS patient; reintroducing a source of lactose into the diet of a lactose-intolerant, IBS patient while prophylactically reducing gastrointestinal IBS symptom severity and/or symptom occurrence in the IBS patient; and/or reducing the severity and/or occurrence of non-gastrointestinal symptoms in a lactose-intolerant, IBS patient.
    Type: Application
    Filed: November 27, 2020
    Publication date: January 5, 2023
    Inventors: Louise Kristine Vigsnæs, Bruce McConnell, Dorthe Seitzberg, Ingvild Dybdrodt Amundsen
  • One or more HMOs for reducing or preventing fatigue and/or improving focus or concentration
    Patent number: 11541069
    Abstract: The invention relates to a human milk oligosaccharide (HMO) for use in reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity in a human. The invention also relates to a synthetic composition for use, comprising one or more of said HMOs. The invention further relates to a method for reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity by administering at least one HMO and the use of said one or more HMOs in a dietary management of a human.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: January 3, 2023
    Assignee: Glycom A/S
    Inventors: Bruce McConnell, Louise Kristine Vigsnæs, Ingvild Dybdrodt Amundsen
  • ONE OR MORE HMOS FOR REDUCING OR PREVENTING FATIGUE AND/OR IMPROVING FOCUS OR CONCENTRATION
    Publication number: 20200338100
    Abstract: The invention relates to a human milk oligosaccharide (HMO) for use in reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity in a human. The invention also relates to a synthetic composition for use, comprising one or more of said HMOs. The invention further relates to a method for reducing or preventing fatigue and/or improving focus or concentration on a mental or physical activity by administering at least one HMO and the use of said one or more HMOs in a dietary management of a human.
    Type: Application
    Filed: November 2, 2017
    Publication date: October 29, 2020
    Inventors: Bruce McConnell, Louise Kristine Vigsnæs, Ingvild Dybdrodt Amundsen